Abstract
Measured tobacco dependence is typically only modestly related to tobacco withdrawal severity amongst regular smokers making a quit attempt. The weak association between dependence and withdrawal is notable because it conflicts with core theories of dependence and because both measures predict cessation outcomes, suggesting they both index a common dependence construct. This study used data from a smoking cessation comparative effectiveness trial (N = 1504) to characterize relations of tobacco dependence with craving and negative affect withdrawal symptoms using multiple dependence measures and analytic methods to detect both additive and interactive effects and to determine whether withdrawal meaningfully mediates the influence of dependence on smoking cessation. We conclude: (1) while univariate analyses suggest dependence and withdrawal measures are only modestly interrelated, more powerful analytic techniques show they are, in fact, meaningfully related and their shared variance is associated with cessation likelihood; (2) there are clear differences between craving and negative affective withdrawal symptoms, with the former more related to smoking heaviness and the latter related to trait measures of negative affect; moreover, craving more strongly mediates dependence effects on cessation; (3) both craving and negative affect withdrawal symptoms are strongly related to a pattern of regular smoking that is sensitive to the passage of time and powerfully affected by smoking cues. These findings support models that accord an important role for associative processes and withdrawal symptoms, especially craving, in drug dependence. The findings also support the use of withdrawal variables as criteria for the evaluation of dependence measures.
Keywords: Tobacco dependence, withdrawal, smoking cessation, craving, negative affect
Regular, daily smokers differ from one another markedly in measured nicotine dependence, and in its correlates. For instance, only about half of regular smokers earn diagnoses of dependence using DSM-IV criteria (Breslau, Johnson, Hiripi, & Kessler, 2001). In addition, regular smokers clearly vary in their ability to stop smoking, which, in turn, appears to reflect the influence of dependence (e.g., Baker et al., 2007). The link between dependence and smoking outcomes leads to the plausible assertion that highly dependent smokers are at risk for relapse because they are prone to experiencing severe post-quit withdrawal symptoms. Yet, in most research, measures of regular smokers’ tobacco dependence is only modestly related to the severity of their tobacco withdrawal syndrome (e.g., r’s ≤ .30; Payne, Smith, McCracken, McSherry, & Antony, 1994; Piper, McCarthy, & Baker, 2006; Rios-Bedoya, Snedecor, Pomerleau, & Pomerleau, 2008; Shiffman, Waters, & Hickcox, 2004). For instance, a recent study using multiple measures of dependence found no significant relations between dependence on the one hand and craving and negative affect withdrawal symptoms on the other hand (Robinson et al., 2011). The examination of the dependence-withdrawal relation in regular smokers may restrict the range of withdrawal and dependence variables versus what would be observed in broader populations of smokers (e.g., Donny, Griffin, Shiffman, & Sayette, 2008), and this may limit levels of association. However, there is reason to believe that measures of these two constructs (dependence and withdrawal) should be substantially related even amongst regular smokers: e.g., there is considerable range in both sorts of measures amongst regular smokers (Fiore, Bailey, & Cohen, 2000; Piasecki et al., 2000; Shiffman et al., 2006), and both dependence and withdrawal measures significantly predict smoking cessation outcomes (Baker, et al., 2007; Piasecki, Jorenby, Smith, Fiore, & Baker, 2003), suggesting that both index a common dependence construct. Moreover, some core theories of addiction assert that dependence influences both withdrawal and relapse, with withdrawal being a sine qua non of dependence and a driving force behind relapse (Edwards & Gross, 1976; Siegel, 1983; Solomon & Corbit, 1974; Wikler, 1980).
Relations between tobacco dependence and withdrawal severity amongst regular smokers may be modest for multiple reasons. First, dependence appears to be multifactorial (Piasecki, et al., 2000; Piper et al., 2004; Shiffman, et al., 2004), and it may be that stronger relations would be observed with some dependence subfactors than with others. Withdrawal also seems to be multifactorial. Recent animal research points to both affective and nonaffective, or somatic, types of withdrawal symptoms, which differ from one another in both mechanism and motivational significance (Hiroi & Scott, 2009; Jackson, Martin, Changeux, & Damaj, 2008). Research with humans also shows evidence of distinct withdrawal subtypes. There is evidence that affective withdrawal symptoms tend to be more highly associated with one another than they are with craving, and that these two symptom types (affective symptoms and craving) have different prevalences and time courses or profiles following abstinence (e.g., Dawkins, Powell, Pickering, Powell, & West, 2009; Hughes, 2007; Sayette, Martin, Hull, Wertz, & Perrott, 2003; also, Smith et al., 2008). Other research shows that affective symptoms and craving differ in variability and account for orthogonal proportions of variance in cessation outcomes (Piper, Cook, Schlam, Jorenby, & Baker, 2011); also see (Berkman, Dickenson, Falk, & Lieberman, 2011). Finally, factor analyses reveal distinct craving and negative affect factors (Piasecki, et al., 2000). So, while negative affect and craving withdrawal symptoms are related to one another (e.g., Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Hendricks, Ditre, Drobes, & Brandon, 2006), there is evidence that they confer different information about withdrawal severity, and have different relations with other measures.1 Their meaningful association reflects the fact that they share some causal influences in common (e.g., tobacco deprivation; Hughes, 2007), and that negative affect per se is causally determinant of craving (Baker et al., 2004). However, it also seems clear that each can reflect different causal influences (e.g., immediate availability of tobacco may elicit craving, but not necessarily negative affect; Carter & Tiffany, 2001; Gloria, Angelos, Schaefer, Davis, et al., 2009). Given the multifactorial natures of dependence and withdrawal, it may be that overarching composite measures may obscure or underestimate their potential for association. The reported research addressed this potential limitation by using multidimensional measures of both dependence and withdrawal and by using real-time assessment of withdrawal symptoms (e.g., Stone et al., 1998).
The current study uses data from a smoking cessation randomized clinical trial (RCT) to characterize the relations between tobacco dependence and tobacco withdrawal symptoms. We selected measures and analytic methods to favor the detection of meaningful relations between these constructs. The analytic strategies used were based on hypotheses about why dependence and withdrawal measures had not been more strongly inter-related in past research. Analyses addressed: (1) How strongly multiple dependence and withdrawal measures were related to one another, and whether the magnitudes of these relations differed meaningfully across the different types of measures. These analyses, therefore, addressed the hypothesis that prior research showed modest inter-relations because it did not adequately canvass measures within the dependence and withdrawal domains. (2) Whether conjoint use of multiple dependence measures would significantly improve the prediction of withdrawal symptoms, i.e., did the various types of dependence measures exert additive, orthogonal effects in their relations with withdrawal symptoms. (3) Whether statistically controlling for nondependence factors (e.g., psychopathology, environmental factors) would improve the prediction of withdrawal scores by dependence measures. These analyses tested the notion that withdrawal is influenced by diverse factors, and that statistically isolating the variance that reflects nondependence influences, would more sensitively reflect dependence-withdrawal relations. (4) Whether smokers differ substantially from one another in terms of which dependence measures show the strongest relations with withdrawal. These analyses tested the notion that there are subpopulations of smokers and that the magnitude of dependence-withdrawal relations can be most sensitively determined if analyses reflect these subpopulations. (5) Whether the relations observed between dependence and withdrawal are clinically meaningful; i.e., whether withdrawal mediates the influence of dependence on cessation outcome.
While numerous dependence measures were used in this research, substantive considerations and empiric evidence suggest a general classification strategy for grouping such instruments. Dependence instruments can generally be considered as omnibus instruments that reflect diverse dependence facets or motives (e.g., the Fagerstrom Test of Nicotine Dependence [FTND], the Tobacco Dependence Screener [TDS], the Nicotine Dependence Syndrome Scale [NDSS], and the Wisconsin Inventory of Smoking Dependence Motives [WISDM]), or as more specific subscales that reflect relatively discrete dependence components. The more discrete scales can be interpreted both with regard to their specific content domains (e.g., relatively pure measures of smoking heaviness, tolerance, specific dependence motives) and with regard to two general, overarching factors (Piasecki, Piper, & Baker, 2010a, 2010b; Piasecki, Piper, Baker, & Hunt-Carter, 2011; Piper, Bolt, et al., 2008). The first of these general factors describes a pattern of smoking that is heavy, automatic, and characterized by a sense of loss of control. The second factor captures smoking motives that involve the instrumental use of smoking: e.g., smoking to reduce distress, enhance pleasure, and improve cognition. This latter type of dependence motive might be conceived of as strategic rather than automatic. The WISDM subscales tapping the first factor have been labeled the Primary Dependence Motives (PDM), and include the Automaticity, Tolerance, Craving, and Loss of Control subscales. The subscales tapping the second factor have been labeled the Secondary Dependence Motives (SDM) and include all other WISDM subscales: e.g., smoking for Negative Reinforcement, Positive Reinforcement, Cognitive Enhancement, and so on. Research and content analysis suggest that some of the subscales from the NDSS (another multidimensional dependence instrument) also assess heavy smoking that is invariant across time and place. In particular, the NDSS Drive and Continuity subscales are associated with high cotinine levels (reflecting heavy self-administration) and with difficulty abstaining from smoking (Shiffman, et al., 2004). The NDSS Drive subscale focuses on the need to smoke fairly continuously over time, and the NDSS Continuity scale focuses on highly regular, invariant smoking over time and place. The characterizations of dependence afforded by these different measures (i.e., heavy, automatic smoking vs. instrumental smoking) will be used in this research to identify dependence features that are, and are not, associated with withdrawal severity.
Together, the analyses conducted for this research test core assumptions of dependence models: that dependence and withdrawal are meaningfully related to one another and account for clinically important outcomes such as cessation ability. As noted, most models of dependence hold that withdrawal is a central manifestation of dependence (e.g., Ahmed & Koob, 2005). If, under highly favorable conditions, relations are modest or negligible in regular smokers, this finding would encourage new thinking about why indices of these theoretically linked constructs do not cohere more strongly (e.g., because withdrawal develops early over the course of nicotine use, and does not reflect accurately higher levels of dependence or tobacco use: e.g., Dierker & Mermelstein, 2010). Further, such results could support dependence models that do not accord an important role for withdrawal distress in drug motivation (e.g., incentive models; Robinson & Berridge, 1993).
Methods
Procedure
Participants were recruited via TV, radio and newspaper advertisements, community flyers, and earned media (e.g., radio and TV interviews, press releases) in the greater Madison and Milwaukee, WI areas. Primary inclusion criteria included: smoking at least 10 cigarettes per day for the past 6 months and being motivated to quit smoking. Exclusion criteria included: certain medications (including monoamine oxidase inhibitors, bupropion, lithium, anticonvulsants, and antipsychotics); any history of psychosis, bipolar disorder, or an eating disorder; consuming six or more alcoholic beverages daily 6 or 7 days a week; pregnancy or breast-feeding; and a serious health condition that would preclude use of study medications or adversely affect study participation. Characteristics of the sample (N=1504) in prevalence (%) and means (SD) were: female n=876 (58%), married n=667 (44.5%), employed for wages n=1,020 (68%), completed only a high school education n=353 (24%), White n=1,258 (83%), Black n=204 (14%), age = 44.7 (11) years, number of previous quit attempts = 5.7 (9.7), FTND Total = 5.4 (2.1), cigarettes smoked/day = 21.4 (8.9), and baseline CO = 25.8 ppm (12.5). This study was approved by the University of Wisconsin-Madison Health Sciences Institutional Review Board.
Eligible participants provided written informed consent and then completed several baseline assessments including a medical history screening, vital signs measurements, a carbon monoxide (CO) breath test and demographic, smoking history and tobacco dependence questionnaires. Participants were randomized to one of six treatment conditions: Bupropion SR (n=264); Nicotine lozenge (n=260); Nicotine patch (n=262); Nicotine patch + Nicotine lozenge (n=267); Bupropion SR + Nicotine lozenge (n=262) or Placebo (consisting of five placebo conditions that matched the five active conditions; n=189). All medications were provided for 8 weeks post-quit except the nicotine lozenge which was provided for 12 weeks post-quit (consistent with prescribing instructions). Randomization was conducted in a double-blind fashion using a randomization scheme with blocking on gender and race (White vs. non-White). All participants received six individual evidence-based counseling sessions (3 and 1 weeks before the quit day, on the quit day, and 1, 2, and 4 weeks after the quit day; each lasting 10–20 minutes), designed to provide social support and training in problem-solving and coping skills (Fiore et al., 2008). Bachelor-level case managers provided manualized counseling and were supervised by a licensed clinical psychologist.
Measures
At baseline, which typically occurred within 2 – 3 weeks of the quit attempt, participants completed a Tobacco History Questionnaire that assessed: gender, ethnicity, age, marital status, education level, employment, and smoking history features such as number of cigarettes smoked per day, age at smoking initiation, residing with other smokers, and number of prior quit attempts. Participants also completed multiple tobacco dependence questionnaires including the FTND (Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991), the NDSS (Shiffman, et al., 2004), the WISDM (Piper, et al., 2004), and the Tobacco Dependence Screener (TDS; Kawakami, Takatsuka, Inaba, & Shimizu, 1999). Nondependence measures included the Minnesota Personality Questionnaire (MPQ; Patrick, Curtin, & Tellegen, 2002), the Positive and Negative Affect Scale (negative affect items: NPANAS; (Watson, Clark, & Tellegen, 1988), and the Social Readjustment Rating Scale (Holmes & Rahe, 1967).
The FTND
This 7-item scale is the most frequently used measure of tobacco dependence. It has only modest internal consistency (α’s = .56 – .70; Piper, et al., 2006), but is a good predictor of biomarkers of smoking heaviness and the likelihood of returning to smoking following a quit attempt (Bolt et al., 2009; Heatherton, et al., 1991). Two FTND items (1 & 4, which assess time to initiate smoking the first cigarette of the day and number of cigarettes smoked/day) have been shown to be particularly predictive of smoking heaviness and cessation success (Baker, et al., 2007; Bolt, et al., 2009; Heatherton, Kozlowski, Frecker, Rickert, & Robinson, 1989).
The NDSS
The NDSS (Shiffman, et al., 2004) is a 23-item self-report measure with five subscales: Tolerance, Drive, Stereotypy, Continuity, and Priority. The internal consistencies of the subscales range from fair to good (.55 – .84; Piper, et al., 2006; Shiffman, et al., 2004). The NDSS correlates well with other measures of tobacco dependence and with measures of smoking heaviness and relapse vulnerability (e.g., Piper, McCarthy, et al., 2008; Shiffman & Sayette, 2005; Shiffman, et al., 2004).
The WISDM-68
The WISDM (Piper, et al., 2004) is a 68-item measure that assesses 13 theoretically derived motivational domains thought to contribute to tobacco dependence: Affiliative Attachment, Automaticity, Behavioral Choice/Melioration, Cognitive Enhancement, Craving, Cue Exposure/Associative Processes, Loss of Control, Negative Reinforcement, Positive Reinforcement, Social and Environmental Goads, Taste and Sensory Properties, Tolerance, and Weight Control. Subscales have good-to-high internal consistence (α’s = .80 – .96). Most subscales correlate significantly with other measures of tobacco dependence and with measures of smoking heaviness, but show variability in such relations given their multidimensionality. Variance in the overall WISDM score reflects the influence of two major factors labeled as Primary and Secondary Dependence Motives (PDM & SDM; see Piasecki, et al., 2011). The PDM comprises the Automaticity, Craving, Loss of Control, and Tolerance subscales, while the SDM comprises the remaining subscales. The former are especially highly related to core dependence features (smoking heaviness, other valid dependence scales, laboratory self-administration of nicotine, genetic risk, and relapse likelihood). The SDM appear to be more related to severity of tobacco withdrawal symptoms (Piasecki, et al., 2010a). Associations with other variables are often clarified when these two scales have their shared variance statistically controlled (Piasecki, et al., 2010a; Piper, Bolt, et al., 2008).
The TDS
This 10-item self-report measure of tobacco dependence was designed to assess International Classification of Diseases (10th revision; ICD-10), DSM-III-R (3rd ed., revised), and DSM-IV symptoms of dependence (Kawakami, et al., 1999). It has shown good internal consistency (α’s ranged from .76 to .81 across three studies) and is significantly correlated with the number of cigarettes smoked per day, years smoking, and carbon monoxide levels.
Multidimensional Personality Questionnaire—Brief Form (MPQ-BF)
The MPQ-BF assesses three personality dimensions: positive emotionality, negative emotionality, and constraint (i.e., lower impulsiveness, risk taking, and rebelliousness). The MPQ-BF has demonstrated excellent internal consistency, stability, factorial validity, convergent and discriminant validity, and correspondence with the extended version of the MPQ (Patrick, et al., 2002; Tellegen, 1982). Based on substantive factors, only the Negative Emotionality and the Constraint scales were used in analyses.
Positive and Negative Affect Scale (PANAS)
The negative affect items from the PANAS were used to assess past 24 hr negative affect.
Social Readjustment Rating Scale
Participants rated whether or not 43 different stressors had occurred over the past year (Holmes & Rahe, 1967).
Withdrawal symptom reports
Participants completed real-time (ecological momentary assessment: EMA) reports four times a day (just after waking, prior to going to bed and at two other random times; all prompts were separated by at least an hour) for up to 2 weeks pre-quit and 2 weeks post-quit. Data analyzed in this research used reports over the 10 days immediately post-quit. EMA reports asked participants to rate how they felt within the last 15 minutes in terms of withdrawal symptoms (negative affect, craving, hunger, and difficulty concentrating) using items from the Wisconsin Smoking Withdrawal Scale (WSWS; Welsch et al., 1999) scored on a 10-point scale. Subjects were trained on how to interpret and respond appropriately to EMA items. The Craving items were: “Bothered by desire to smoke a cigarette,” and “Urge to smoke.” The Negative Affect withdrawal items were: “Tense or anxious,” “Impatient,” “Bothered by negative moods such as anger, frustration, and irritability,” “Irritable or easily angered,” “Sad or depressed “ and “ Hopeless or discouraged.” For the craving measure, M = 4.14 (SD = 2.67) with a range of 10. For the negative affect measure, M = 1.55 (SD = 1.48) with a range of 9.17, and the two measures were intercorrelated at .51.
Data Analysis
Zero-order correlations amongst the diverse dependence scales were computed. A broad range of correlation magnitudes would allow the various measures to yield additive effects with regard to the prediction of withdrawal. The dependence scales were then correlated with the two types of withdrawal symptoms (craving and negative affect). Mean post-quit withdrawal craving and mean negative affect scores derived from the EMA reports were selected as the withdrawal symptom variables because of evidence that they reflect different withdrawal factors and share distinct relations with dependence measures (e.g., Piasecki, et al., 2000; Piper, Loh, Smith, Japuntich, & Baker, 2011). Symptom means, rather than some other symptom profile dimension such as trajectory (Piasecki, et al., 2003), were used since it seemed conceptually appropriate to use a dimension that reflects the overall severity of symptoms across relevant time periods.2 As in other analyses in this work, treatment condition (with categorical coding for placebo, monotherapy, and combination therapy) was used as a covariate since treatment could have affected withdrawal severity, independent of dependence level.
Because of evidence that the WISDM-68 PDM and SDM measures capture two distinct tobacco dependence factors, the two withdrawal indices (craving and negative affect) were regressed on both PDM and SDM (Piasecki, et al., 2010a; Piper, Bolt, et al., 2008). In addition, multiple regression analyses were conducted in which the craving and negative affect means were regressed on PDM and SDM scores residualized for one another, with treatment condition used as a covariate. As noted, such residualizing clarifies the relations of PDM and SDM with other variables (Piasecki, et al., 2010a, 2010b; Piper, Bolt, et al., 2008). Finally, because the relations of PDM have been attributed to their ability to index smoking heaviness, we assessed the relation between withdrawal (craving and negative affect) and reported cigarettes smoked per day to determine if the relation of PDM with withdrawal could be accounted for by smoking heaviness per se.
Next, best-fitting models for both craving and negative affect withdrawal symptoms were built (Hosmer & Lemeshow, 2000). These analyses were designed to determine if dependence-withdrawal relations would be strengthened when sources of variation in withdrawal scores other than dependence were statistically controlled. These models also tested the notion that multiple, different dependence measures would exert additive effects in the prediction of withdrawal, consistent with the multifactorial nature of dependence. In addition to specific dependence measures (as well as global measures of dependence such as the FTND, TDS, and NDSS and WISDM total scores), candidate variables in these models included environmental factors and nondependence person factors that might also predict withdrawal symptom levels: e.g., recent stressors, presence of smokers and smoking cues, amount of smoking restrictions in the person’s daily life, age, gender, treatment, and neuroticism. These variables were added to determine if controlling for error variance in the withdrawal scores might clarify and strengthen predictive relations with dependence measures. Model building methods involved inspection of distributional properties of the variables, initial selection of predictors based upon substantive and empirical grounds (univariate p-values < .25), systematic stepwise forward model building with backwards deletion, examination of collinearity, and tests of all two-way interactions between treatment and dependence variables.3
Because relations between dependence and withdrawal could vary across subpopulations of smokers, regression tree models were tested in which both dependence measures and theoretically relevant covariates (e.g., recent stressors, smoking restrictions, age, treatment, gender), were used in models to predict withdrawal. This was done because regression tree models are less dependent upon model specification than are regression strategies. For example, if a linear regression model is assumed and the true model is nonlinear, each coefficient in the linear regression model represents an average slope, at best. The regression tree model, on the other hand, quantifies the overall prediction power of the variable without any prior assumptions about the exact form of the model, because the complexity of the model automatically adapts itself to the information content and the complexity of the data (e.g., by identifying the optimal cut-scores for continuous measures; Loh, 2002; Piper, Loh, et. al, 2011).4 These features make regression tree modeling an appropriate strategy given that the goal is to optimize dependence-withdrawal associations. As in the model-building analyses, individual WISDM and NDSS subscales, in addition to global dependence measures, were used to achieve a high resolution with regard to the modeling of specific dependence factors.
Finally, mediational models were tested to determine the extent to which variance in withdrawal mediated the influence of dependence on cessation ability. Two types of mediational models were estimated. Initially, multiple- mediator models were specified using both craving and negative affect withdrawal symptoms as mediators. Models were specified using different (individual) measures of dependence (the X variable), along with two mediators (post-quit craving and negative affect as the M variables), and a days-to-relapse outcome over 8 weeks post-quit (the Y variable). The days-to-relapse outcome was modeled as a survival outcome, with participants who failed to relapse treated as right-censored observations, and each path to relapse thus being interpreted on a logit metric corresponding to the likelihood of a relapse i.e., positive values indicating a higher probability of relapse. Both treatment and smoking during the period of withdrawal measurement (a binary variable reflecting smoking, on average, 5 cigarettes/day or less [coded “1”] vs. more than this amount [coded “0”]; see Piper, McCarthy, et al., 2008) were controlled by regressing variables in the mediational model onto these relevant categorical variables.
In the second type of mediational model, combinations of dependence measures were used as predictor (X) variables in the models (i.e., WISDM Tolerance, WISDM Drive, and WISDM Cue Exposure) with the craving withdrawal measure as the sole mediator (since it proved to be the strongest mediator in the first set of mediational analyses). This was done to estimate the magnitude of the effect of dependence on withdrawal and relapse when optimal measures of dependence were jointly employed. These three dependence measures were selected since they had the strongest relations with withdrawal across the craving and negative affect best-fitting models. The mediational models were fit in Mplus 6.1 (Muthen & Muthen, 2010) using the MLR (maximum likelihood with robust standard errors) estimator and Monte Carlo integration to account for the censored observations. Indirect effects were tested using a joint significance test approach, whereby statistically detectable mediation occurs when both paths in the indirect effect—the path from dependence to mediator, and from mediator to relapse—are found statistically significant (MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002). To evaluate effect sizes for the mediational effects, we used a measure of the mediational pathway estimates in reference to the metrics of the relevant variables. As the outcome is a survival outcome, the effects can all be interpreted with respect to the relative likelihood of relapse.
Results
Dependence and Withdrawal Correlations
Table 1 shows that intercorrelation of the full dependence scales used in this research generated a sizable range of correlations, suggesting that some of the measures could contribute orthogonal variance to the prediction of withdrawal. The WISDM and NDSS subscales also showed considerable range in their correlations with other measures of dependence. For instance, the correlations of the WISDM subscales with the FTND total score ranged from .05 –.70 (for the Weight Control and Tolerance subscales, respectively). Table 2 displays the relations of the two withdrawal measures used in this research (craving and negative affect) with the full dependence scales and with smoking heaviness (cigarettes smoked/day). Table 2 shows some variation in prediction magnitude, but the levels of association are all modest in size, consistent with prior research (e.g., Piper, et al., 2006; Shiffman, et al., 2004), accounting for less than 10% of the variance in symptom magnitude. However, it is clear that most of the dependence scales predicted withdrawal symptoms better than a simple measure of smoking heaviness per se (cigarettes smoked/day).
Table 1.
Interrcorrelations of major dependence measures.
| Measures | TDS | WISDM | PDM | SDM | NDSS |
|---|---|---|---|---|---|
| FTND | .21 | .39 | .56 | .25 | .45 |
| TDS | .37 | .32 | .35 | .37 | |
| WISDM | .80 | .96 | .61 | ||
| PDM | .59 | .63 | |||
| SDM | .51 |
Note. N’s = 1442–1500. TDS = Tobacco Dependence Screener; WISDM = Wisconsin Inventory of Smoking Dependence Motives; PDM=Primary Dependence Motives; SDM=Secondary Dependence Motives; NDSS=Nicotine Dependence Syndrome Scale. All correlations significant at p <.01.
Table 2.
Relations amongst dependence measures and craving and negative affect withdrawal symptoms.
| Measures | Post-quit Craving | Post-quit Negative Affect | ||
|---|---|---|---|---|
|
| ||||
| r | 95% C.I. | r | 95% C.I. | |
| FTND | .258** (N=1283) | .207–.308 | .138** (N=1283) | .084–.191 |
| TDS | .216** (N=1281) | .164–.267 | .227** (N=1281) | .175–.278 |
| NDSS | .305** (N=1234) | .254–.354 | .208** (N=1234) | .154–.260 |
| WISDM-68 | .308** (N=1282) | .258–.356 | .236** (N=1282) | .184–.287 |
| SDM | .264** (N=1281) | .213–.314 | .235** (N=1282) | .183–.286 |
| SDM controlling for PDM | .127** (N=1281) | .073–.180 | .210** (N=1281) | .158–.261 |
| PDM | .306** (N=1282) | .256–.354 | .166** (N=1282) | .113–.218 |
| PDM controlling for SDM | .234** (N=1281) | .182–.285 | .044 (N=1281) | .000–.098 |
| Cigarettes per day | .120** (N=1279) | .066–.173 | .048 (N=1279) | .000–.102 |
Note. The correlations shown above were not adjusted for treatment conditions. The same pattern of association was obtained when treatment condition was statistically controlled. FTND = Fagerstrom Test of Nicotine Dependence; TDS = Tobacco Dependence Screener; NDSS = Nicotine Dependence Syndrome Scale; WISDM-68 = Wisconsin Inventory of Smoking Dependence Motives; SDM = Secondary Dependence Motives; PDM = Primary Dependence Motives.
significant at p <.01
To achieve more discrete assays of dependence, the PDM and the SDM, derived from the WISDM, were correlated with the withdrawal indices. In addition, orthogonal variance in these two dependence factors was identified (via partialling their shared variance), and the withdrawal indices were then regressed on these partialled factors. Table 2 reveals that using the relatively discrete WISDM dependence PDM and SDM motives did not result in meaningfully larger associations with withdrawal scores. The zero-order correlations show that the partialled SDM residual was significantly more highly related to Negative Affect than was the residualized PDM score (r’s = .210 vs. .044), while the residualized PDM score was significantly more highly related to Craving than was the residualized SDM score (r’s = .234 vs. .127; see Table 2 for confidence intervals).
Best-Fitting Models
Best-fitting models were then built for the prediction of each of the two withdrawal measures (Hosmer & Lemeshow, 2000). These models captured the optimal set of main effect predictors for each type of withdrawal symptom, statistically controlling for the influence of exogenous factors that could affect the withdrawal variables (to reduce error). Candidate predictors included multiple, specific dependence measures because such measures might summate to enhance predictive validity. To accomplish this, every subscale of the two multifactorial dependence measures (the WISDM and the NDSS) was evaluated along with the omnibus tobacco dependence measures—the TDS, and the FTND (total score plus separate inclusion of the two items that constitute the Heaviness of Smoking Index [Items 1 & 4]). The nondependence predictors included: treatment condition, age, gender, educational attainment, relevant personality dimensions (MPQ Negative Emotionality, Constraint), stressors (Social Readjustment Rating Scale), social network factors (number of smokers in the social network, number of supportive others in the social network, presence of a spouse/partner who smokes), presence of smoke-free environments (home and work smoking restrictions), mood (baseline NPANAS), and history of panic attacks (a common anxiety diagnosis associated with relapse vulnerability; Piper, Cook, et al., 2011). Of these measures, age, gender, and treatment condition were retained in models on substantive bases (Hosmer & Lemeshow, 2000). Tables 3a and 3b depict the Negative Affect and Craving analyses, respectively.
Table 3a.
Best fitting model for predicting negative affect withdrawal symptoms.
| Variables | B | Std. Error | Beta | t | Sig. |
|---|---|---|---|---|---|
| (Constant) | −.990 | .274 | −3.619 | .000 | |
|
| |||||
| FTND | .045 | .019 | .065 | 2.422 | .016 |
| TDS | .060 | .022 | .074 | 2.690 | .007 |
| NDSS Continuity | .146 | .038 | .104 | 3.871 | .000 |
| WISDM Cue Exposure | .133 | .033 | .108 | 3.984 | .000 |
| Baseline PANAS – Negative affect | .056 | .006 | .263 | 9.090 | .000 |
| MPQ Negative Emotionality | .018 | .003 | .165 | 5.476 | .000 |
| SRRS Total | .001 | .000 | .086 | 3.218 | .001 |
| Age | −.008 | .004 | −.060 | −2.282 | .023 |
| Gender | .171 | .077 | .057 | 2.214 | .027 |
| Treatment | −.207 | .058 | −.091 | −3.583 | .000 |
Note. R = .24.
Table 3b.
Best fitting model for predicting craving withdrawal symptoms
| Variables | B | Std. Error | Beta | t | Sig. |
|---|---|---|---|---|---|
| (Constant) | −.129 | .508 | −.253 | .800 | |
|
| |||||
| FTND | .135 | .047 | .108 | 2.904 | .004 |
| NDSS Continuity | .152 | .068 | .060 | 2.222 | .026 |
| NDSS Drive | .311 | .078 | .122 | 4.009 | .000 |
| WISDM Automaticity | −.115 | .051 | −.072 | −2.240 | .025 |
| WISDM Cue Exposure | .299 | .070 | .135 | 4.295 | .000 |
| WISDM Tolerance | .301 | .079 | .156 | 3.810 | .000 |
| Baseline PANAS – Negative affect | .051 | .010 | .132 | 4.874 | .000 |
| Age | .012 | .007 | .048 | 1.747 | .081 |
| Gender | .481 | .143 | .089 | 3.351 | .001 |
| Treatment | −.431 | .108 | −.105 | −4.000 | .000 |
Note. R2 = .18.
To reveal the extent to which the most predictive dependence measures can increment predictive accuracy when major sources of nondependence variance are statistically controlled, the nondependence measures were first forced into the models as a set, and then the dependence measures with significant associations were entered as a set. Results showed that the set of dependence measures resulted in a modest, but significant, increment in prediction for the Negative Affect model (the R2 increased from .202 to .236), and a somewhat larger, and significant, increment in prediction for the Craving model (an increase in model R2 from .06 to .178). Both models comprised both omnibus (e.g., FTND) and specific (individual NDSS and WISDM subscales) dependence measures.
Regression Tree Models
Piecewise-constant regression tree models were then generated with GUIDE software (Loh, 2002) using the same variables tested in the regression model fitting analyses: e.g., gender, treatment, and presence of home or work smoking restriction rules. Separate models were run for the Craving and Negative Affect withdrawal symptoms. Each tree model was obtained by first growing a large tree, using chi-squared significance tests to choose a variable to split the data at each node of the tree. Then the tree was pruned back to produce a nested sequence of smaller tree models. The tree model with the smallest mean squared error estimated by ten-fold cross-validation was selected. The splitting algorithm is detailed in Loh (2002) and the pruning algorithm in Breiman et al. (1984, Chap. 3) (Breiman, Friedman, Olshen, & Stone, 1984).
The Negative Affect regression tree model had only one predictor: the WISDM Behavioral Choice/Melioration scale (see Figure 1a). This finding shows only a modest association between this SDM subscale and negative affect such that those with a Behavioral Choice score of less than 3.8 had a Negative Affect score of only 1.3, on average (on a 10-point scale), while those with a higher Behavioral Choice score had a Negative Affect score of 1.9, on average, a statistically significant difference (p = 2.1 × 10 −12).
Figure 1.
Figure 1a. Regression tree predicting mean post-quit negative affect.
Figure 1b. Regression tree predicting mean post-quit craving.
The Craving withdrawal score was predicted jointly by three different predictors: the WISDM Tolerance score, the WISDM Cue Exposure score, and the NDSS Drive score (see Figure 1b). The lowest levels of craving postquit were produced by those who were low on both the WISDM Tolerance scale (≤ 5.50) and the NDSS Drive score (≤ −1.14). The highest scores were produced by those who were high on both the WISDM Tolerance scale (>5.50) and the WISDM Cue Exposure scale (> 6.09). Figure 1b shows that the 172 smokers with low scores (below the cut-score) on the WISDM Tolerance and the NDSS Drive measures had a mean Craving score postquit of 2.28, while the 122 smokers with high scores on the WISDM Tolerance and WISDM Cue Exposure measures (above the cut-scores) had a mean Craving score post-quit of 6.30 (differences across the four mean symptom levels are significant with an ANOVA F-test: p = 2.2 × 10 −16).
Mediational Models
The initial set of multiple-mediator models comprising both Craving and Negative Affect withdrawal symptoms as mediators, revealed that, across different dependence measures, only the Craving withdrawal measure supported a significant mediational path. (Analyses revealed that negative affect could support a significant mediational path, but this path became nonsignificant once Craving was added to the model.) Therefore, the second set of mediational models, those comprising multiple dependence measures, used only Craving as the withdrawal mediator.
Therefore, to determine the extent to which variance shared by dependence and withdrawal measures was motivationally and clinically meaningful, joint mediation analyses were conducted using two dependence subscales (the WISDM Tolerance and the NDSS Drive subscales) as the X variables, with the Craving withdrawal measure as the M variable, and relapse latency over the first 8 weeks postquit as the Y variable (Figure 2). The model controlled for the relations between smoking during the 2-week post-quit withdrawal assessment period with Craving and Relapse, controlled for the relations of treatment with Craving and Relapse (as well as with the dependence measures), estimated the direct effects dependence on relapse, and estimated the indirect path reflecting the mediation of dependence effects on relapse via craving. The dependence measures (i.e., WISDM Tolerance and NDSS Drive) were selected because they were highly associated with Craving in both the best-fitting and regression tree models and because they together produced the largest reductions in Craving residual variance. Figure 2a shows that both WISDM Tolerance and NDSS Drive significantly predict Craving, and Craving significantly predicts Relapse. Figure 2b shows the mediation of both WISDM Tolerance and WISDM Cue Exposure by Craving. Neither NDSS Drive nor WISDM Cue Exposure has significant direct effects on Relapse once the Craving mediator is entered in the models but WISDM Tolerance does continue to predict Relapse.
Figure 2.
Figure 2a. Mediation model showing craving withdrawal symptoms mediating the effect of WISDM Tolerance and NDSS Drive subscale scores on cessation outcome. “Smoking” is a binary variable reflecting smoking during the 2-week post-quit period when withdrawal symptoms were assessed. It reflects average smoking rates during this period of 5 cigarettes/day or less vs. more than this amount. It is intended to control for any influence of moderate or heavy smoking during this period on withdrawal symptoms and relapse.
Figure 2b. Mediation model showing craving withdrawal symptoms mediating the effect of WISDM Tolerance and Cue Exposure subscale scores on cessation outcome. The variable “Smoking” is a binary variable reflecting smoking during the 2-week post-quit period when withdrawal symptoms were assessed. It reflects average smoking rates during this period of 5 cigarettes/day or less vs. more than this amount. It is intended to control for any influence of moderate or heavy smoking during this period on withdrawal symptoms and relapse.
The mediation ratios (MR) for each of the mediational models revealed considerable range in magnitude. The MR’s in the WISDM Tolerance and NDSS Drive model with respect to craving were .17 for WISDM Tolerance and .52 for NDSS Drive, while in the WISDM Tolerance and WISDM Cue Exposure model the MR’s were .18 for WISDM Tolerance and .69 for WISDM Cue Exposure. Thus, with both types of dependence variables, the ratio of indirect effects to total effects was less for WISDM Tolerance than for either NDSS Drive or WISDM Cue Exposure, consistent with the weaker residual direct effects to Relapse observed for NDSS Drive and WISDM Cue Exposure.
The mediational path estimates were also evaluated with reference to the metrics of the relevant variables. As the outcome is a survival outcome, the effects can all be interpreted with respect to the relative likelihood of relapse. More specifically, given a regression coefficient b (or equivalently a product of regression coefficients) related to a predictor X, exp(X*b) indicates the proportional increase (or decrease) in the likelihood of relapse. For example, comparing extreme scores on both the WISDM Tolerance (1 vs. 7) and NDSS Drive (−3.63 vs. 2.47 factor scores), yields indirect effect estimates of .386*.046 =.018 for WISDM Tolerance and .472* .046 = .022, for NDSS Drive (see Figure 2a). This implies that a high scorer on both scales would have about a 30% greater chance of relapse than would a low scorer on both scales because of dependence effects that are mediated by craving: exp(.018*6 + .022*6.1) = 1.27.
Discussion
Consistent with considerable previous research, measures of dependence and withdrawal were modestly related to one another when analyzed with typical univariate regression techniques. Modest relations were obtained whether omnibus dependence scales or more specific subscales were used in univariate analyses. However, these analyses did reveal additional evidence about how withdrawal and dependence are related to one another. First, consistent with other research (Hughes, 2007), there was evidence that withdrawal symptoms are heterogeneous and that, at the very least, craving and affective composites need to be separately analyzed (see Piasecki, et al., 2000; Piper, Schlam, et al., 2011). For instance, we found that craving and negative affect tended to be predicted by different sorts of variables. The best-fitting models showed that while some measures predicted both craving and negative affect withdrawal symptoms (i.e., the FTND, the NDSS Continuity subscale, the WISDM Cue Exposure subscale, and gender), some predictors were related to only one symptom. For instance, the MPQ Negative Emotionality Scale and the SRRS (stressor measure) predicted only the negative affect symptoms. Conversely, the WISDM Tolerance and NDSS Drive subscales predicted only the craving symptoms.
These patterns of predictive relations suggest certain inferences with regard to the causal influences on tobacco withdrawal symptoms. First, both craving and negative affect withdrawal symptoms are significantly related to a pattern of continuous smoking throughout the day (based on salient items for the NDSS Continuity Scale: e.g., “My smoking pattern is very irregular throughout the day. It is not unusual for me to smoke many cigarettes in an hour, then not have another one until hours later” reverse scored). To the extent that a person spends time not smoking, and their smoking pattern is irregular, they are likely to experience reduced affective and craving withdrawal symptoms. Notice that regularity or pattern of smoking seems to be more important than is the number of cigarettes smoked per day, which had low levels of association in zero-order tests and performed poorly in model building tests. (A caveat is that all subjects in this work smoked at least 10 cigarettes per day, so this characterization might not apply to very light smokers.) This observation suggests that an important determinant of withdrawal severity is the cueing of smoking by internal or external cues over the passage of time (Baker, et al., 2004; Kozlowski & Herman, 1984; see the rationale for the NDSS Continuity scale in Shiffman, et al., 2004).
The major discrepancy between the two withdrawal symptoms (craving and negative affect) as predicted in the best-fitting models is that only craving symptoms are predicted by the WISDM Tolerance and NDSS Drive subscales5, with both subscales showing relatively strong associations (Tables 3a & 3b). Both of these subscales ask about the need to smoke as a function of the passage of time. For instance, the NDSS Drive subscale (based on salient items) focuses on withdrawal related discomfort and craving (“After not smoking for a while, I need to smoke to relieve feelings of restlessness and irritability,” and “After not smoking for a while, I need to smoke in order to keep myself from experiencing any discomfort.”). The WISDM Tolerance subscale also focuses on the difficulty of allowing time to pass without smoking (“I can only go a couple hours between cigarettes,” and “I usually want to smoke right after I wake up.”). Thus, both of these subscales, to some extent, reinforce the message that the passage of time is a critical imperative for smoking. These subscales also assess smoking heaviness (WISDM Tolerance) and the strength of craving per se (NDSS Drive) more directly than does the NDSS Continuity subscale, and this more direct assessment may contribute to their greater association with craving, than with negative affect, withdrawal symptoms. Of course, another key distinction between the predictors of the craving and negative affect models is that measures of neuroticism or negative affect relate more strongly to the latter.
In sum, it appears that a critical correlate of strong withdrawal symptoms measured in real-time is a pattern of highly regular, cue-elicited smoking. It remains unknown why smokers would differ from one another in these determinants of withdrawal severity. Why would one smoker versus another be more likely to form strong cue-withdrawal associations? Perhaps differences in the influence of smoking periodicity might arise from differences in nicotine clearance (Piper, Bolt, et al., 2008; Schnoll et al., 2009) and homeostatic defense of blood nicotine levels (Kozlowski & Herman, 1984). The nature of the cue is also unknown, but the importance of the passage of time suggests the detection of interoceptive signals of withdrawal or cues signaling falling nicotine levels in the body (Baker, et al., 2004; Bevins et al., 2011)
Other evidence suggests that dependence is associated with a shift in influence from exteroceptive to interoceptive cues; a shift most starkly illustrated in research with chippers (aperiodic smokers). Chippers use tobacco regularly but without escalating their use markedly or apparently losing control over its use. In contrast to heavy dependent smokers, whose smoking is fairly constant throughout the day and sensitive to tobacco deprivation, chippers’ smoking is more aperiodic and under greater (apparently external) stimulus control (Coggins, Murrelle, Carchman, & Heidbreder, 2009; Shiffman & Paty, 2006). (Interestingly, the NDSS Drive subscale, which directly assesses how the passage of time affects withdrawal, strongly discriminates chippers from heavier smokers; Shiffman & Sayette, 2005). These findings with chippers reinforce the notion that tobacco dependence that manifests in strong withdrawal (perhaps especially in withdrawal craving), is characterized by an intolerance to a disruption in smoking (also see Piasecki, et al., 2010b). It may be, in fact, that there is a developmental progression such that severe nicotine dependence is associated with a shift to time-based, interoceptive cueing (vs. chippers; Coggins, et al., 2009; Shiffman & Paty, 2006). However, the regression tree analyses suggest that internal cueing does not wholly replace the effects of environmental cueing (see Figure 1b); those individuals prone to both types of cueing are at greatest risk for severe withdrawal craving.
The linkage of chronic, heavy self-administration with sensitivity to cues and abstinence-induced craving accords with considerable recent research on drug dependence. This work shows that heavy, chronic self-administration results in habit learning (mediated by the dorsal striatum; Everitt & Robbins, 2005)—a cornerstone of which is strong stimulus-response bonds that result in the automatic elicitation of drug use in the presence of highly mapped cues (Takahashi, Roesch, Stalnaker, & Schoenbaum, 2007; Vanderschuren, Di Ciano, & Everitt, 2005). Further, research shows that drug deprivation increases activity in the dorsal striatum (Vollstadt-Klein et al., 2010), and this results in strong abstinence induced craving (Volkow et al., 2006; Vollstadt-Klein, et al., 2010). Thus, the linkage of heavy self-administration, sensitivity to drug abstinence, and strong elicitation of craving by abstinence, is consistent with recent basic research on the role of habit learning in addiction.
The predictors comprised by the best-fitting model of the negative affect withdrawal symptoms are different from those comprised by the best-fitting craving model. Not only does the negative affect model comprise multiple measures of affective vulnerabilities, but its nicotine dependence measures are less focused on smoking heaviness. For instance, the DSM symptoms tapped by the TDS scale do not reflect smoking heaviness well (Baker, Breslau, Covey, & Shiffman, 2011), and instead seem to more sensitively reflect psychological distress (Breslau & Johnson, 2000). Therefore, while withdrawal-related negative affect may reflect dependence-related genetic influence (Edwards & Kendler, 2011), withdrawal-related negative affect is not closely related to the core elements of nicotine dependence that have been highlighted in recent research (drug use that is heavy, uniform across time and place, and automatic; see Piasecki, et al., 2010a, 2010b) and that most strongly motivate relapse (see results of the mediational models). This calls into question models that posit a central role for negative affect in dependence (Baker et al., 2004).
The best-fitting models underscore the importance of a multifactorial approach to the assessment of dependence. None of the omnibus dependence measures was able, by itself, to account optimally for the dependence-withdrawal covariation present in the data (see results of the best-fitting models and the regression tree analyses). Multiple scales, including relatively discrete dependence subscales, were able to account for significant increments in variance in the two types of withdrawal symptoms.
Finally, the issue that inspired this research was the question of whether measures of the dependence construct and withdrawal are meaningfully related, which would affirm the theories that posit strong causal relations between these constructs (Edwards & Gross, 1976; Koob, 2006; Siegel, 1983; Solomon & Corbit, 1974; Wikler, 1980). This issue boils down to whether dependence can account for meaningful differences in withdrawal symptom magnitude, and then, whether such differences are consequential. The regression tree analyses showed that dependence measures were related to very large differences in withdrawal symptoms when subpopulations of smokers were considered. Individuals who scored low on both the WISDM Tolerance and the NDSS Drive subscales reported very low levels of craving, while individuals scoring highly on the WISDM Tolerance and WISDM Cue Exposure subscales generated postquit craving scores that were almost three times larger than those reported by the former individuals (see Figure 1b). Thus, optimal combinations of dependence measures can indeed predict large differences in withdrawal scores.
The mediational models pertain to the meaningfulness of the relation of dependence and withdrawal. The mediational analyses allow us to determine if the variance shared by dependence and withdrawal predicts the clinically important outcome of relapse latency. These analyses showed that exemplar dependence measures (e.g., WISDM Tolerance and NDSS Drive) predicted significant variance in relapse latency via their relations with craving. While significant mediation by craving was found, the clinical impact should be viewed as modest in size, with the highest scores on the two exemplar dependence measures increasing risk by only about 30%6. While this level of increase is not large, it must be remembered that relapse is a function of diverse factors and reflects such influences as educational status, self-efficacy, presence of smokers in the home, fortuitous exposure to episodic events (cues, stressors), and comorbid psychopathology (e.g., Bolt, et al., 2009). Given the causally promiscuous nature of relapse, the degree to which relapse was influenced by dependence via withdrawal craving is impressive. Another potentially important finding of the mediational analyses arose from multi-mediator models; viz. the relation between dependence and relapse could be accounted for entirely by craving. That is, dependence appears to increase relapse risk, and it does so via the withdrawal symptom of craving and not negative affect (Berkman, et al., 2011).
This research leaves many questions unanswered and has limitations. One limitation is that the current results might not generalize well to other smoking populations. For instance, this sample participated in a formal cessation trial and this requirement may have selected for smokers who differ from smokers in general on multiple dimensions: e.g., motivation to quit, dependence level, and so on. Another concern is that while the present results elucidate the relation between dependence and withdrawal, the majority of withdrawal variance remains unexplained. A final caveat is that the hypotheses advanced in this research are based upon only self-report of perceived dependence motives and withdrawal. This strategy may have missed important information that would have been captured by measures other than self-report (e.g., physiological or cognitive measures). Future research might use actual behavioral indices of smoking regularity or patterning and physiological assays of self-administered nicotine dose to ground tests of hypotheses with multimethod measures. Finally, the step-wise methods upon which best-fitting model-development depends, have limitation such as inflated R2 values and sample specificity in the ordering of predictors (Harrell, 2001). However, many of the problems encountered with such models arise from multicollinearity with regard to the original set of predictors and concern the exact form of the developed model. Regression based models, though, show good stability in terms of the replication of the particular identified model across derivation to predictor samples (Dreiseitl & Ohno-Machadob, 2002; Harper, 2005). In other words, concerns about replication of such models primarily arise from the consistency with which the same model will be derived from different data sets/samples; derived models often show good stability when the best-fitting predictors are tested in new samples (e.g., Dreiseitl & Ohno-Machadob, 2002). This means that the dependence measures comprised by the models in Tables 3a & b would likely show meaningful relations with withdrawal criteria in new samples (assuming appropriate initial sampling and derivation strategies).
In closing, the results suggest the following conclusions: (1) While univariate analyses suggest that dependence and withdrawal measures tend to be only modestly interrelated, more powerful analytic techniques show that they are, in fact, meaningfully related and their shared variance is related to the important clinical outcome of relapse; (2) There are clear differences between craving and negative affective withdrawal symptoms, with the former more related to smoking heaviness and the latter more related to trait measures of negative affect; moreover, craving exerts stronger effects as a mediator of dependence effects on relapse than does negative affect; (3) Both craving and negative affect withdrawal symptoms, and especially craving, appear to be relatively strongly related to a pattern of regular smoking that is spurred by the passage of time, and that is powerfully affected by smoking cues. These findings support models that accord an important role for withdrawal symptoms, especially craving, and associative processes in drug dependence. These findings also support the practice of using multidimensional withdrawal measures as criteria for the evaluation of dependence measures.
Acknowledgments
Funding: This research was conducted at the University of Wisconsin, Madison and was supported by grant #P50 DA019706 from NIH/NIDA and by grant #M01 RR03186 from the General Clinical Research Centers Program of the National Center for Research Resources, NIH. Dr. Piper was supported by an Institutional Clinical and Translational Science Award (UW-Madison; KL2 Grant # 1KL2RR025012-01). Dr. Cook was supported by K08DA021311. Dr. Baker was supported via NCI 1K05CA139871. Dr. Loh was supported in part by U.S. Army Research Office grant W911NF-09-1-0205. Medication was provided to patients at no cost under a research agreement with GlaxoSmithKline (GSK); no part of this manuscript was written or edited by anyone employed by GSK.
Footnotes
We did not consider other withdrawal symptoms for inclusion because such symptoms as hunger tend to be less important motivationally (e.g., they are not as strongly predictive of cessation outcomes or nicotine self-administration) and tend to cohere with one another less meaningfully (e.g., Piasecki et al., 2000).
Examination of profile components such as symptom trajectory or variability did not enhance relations with dependence, nor did they produce meaningful additive effects. Postquit scores were not partialled for prequit variance since that could remove meaningful withdrawal related variance (Hendricks, et al, 2006).
Only two of these interactions were obtained, they were modest (p> .03), did not change the magnitudes of the dependence withdrawal main effects, and did not change point estimates in the models. Therefore, they were not retained in the models (Hosmer & Lemeshow, 2000).
It is certainly the case that, in theory, the best-fitting models could have tested all possible interaction effects vs. just 2-way interactions with treatment. However, given the number of independent variables, the number of potential interactions would have been prohibitive. The regression tree models provide an efficient method for screening possible influential moderators of outcomes that would cause dependence-withdrawal relations to be especially strong in certain smoker subpopulations.
The WISDM Automaticity subscale was negatively associated with craving symptoms in the best fitting model. However, this appears to be due to suppression effects since it is positively associated with craving in zero-order associations.
When only a single dependence measure (e.g., WISDM Tolerance) was used, an extreme score on that measure increased relapse risk by about 15%, showing that the combined use of dependence measures does enhance the prediction of relapse due to craving mediation.
Disclosures: Timothy B. Baker, Megan E. Piper, Tanya R. Schlam, Jessica W. Cook, Stevens S. Smith, Wei-Yin Loh, and Daniel M. Bolt have no potential conflicts of interest to disclose.
References
- Ahmed SH, Koob GF. Transition to drug addiction: A negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 2005;180:473–490. doi: 10.1007/s00213-005-2180-z. [DOI] [PubMed] [Google Scholar]
- Baker TB, Breslau N, Covey L, Shiffman S. DSM criteria for tobacco use disorder and tobacco withdrawal: A critique and proposed revisions for DSM-5. Addiction. 2011;107:263–275. doi: 10.1111/j.1360-0443.2011.03657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baker TB, Piper ME, McCarthy DE, Bolt DM, Smith SS, Kim SY, Toll BA. Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research. 2007;9(Suppl 4):S555–570. doi: 10.1080/14622200701673480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychological Review. 2004;111:33–51. doi: 10.1037/0033-295X.111.1.33. [DOI] [PubMed] [Google Scholar]
- Berkman ET, Dickenson J, Falk EB, Lieberman MD. Using SMS text messaging to assess moderators of smoking reduction: Validating a new tool for ecological measurement of health behaviors. Health Psychology. 2011;30:186–194. doi: 10.1037/a0022201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bevins RA, Barrett ST, Polewan RJ, Pittenger ST, Swalve N, Charntikov S. Disentangling the nature of the nicotine stimulus. Behavioural Processes. 2011 doi: 10.1016/j.beproc.2011.10.020. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bolt DM, Piper ME, McCarthy DE, Japuntich SJ, Fiore MC, Smith SS, Baker TB. The Wisconsin Predicting Patients’ Relapse questionnaire. Nicotine & Tobacco Research. 2009;11:481–492. doi: 10.1093/ntr/ntp030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Belmont, CA: Chapman & Hall/CRC Press; 1984. [Google Scholar]
- Breslau N, Johnson EO. Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health. 2000;90:1122–1127. doi: 10.2105/ajph.90.7.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breslau N, Johnson EO, Hiripi E, Kessler R. Nicotine dependence in the United States: Prevalence, trends, and smoking persistence. Archives of General Psychiatry. 2001;58:810–816. doi: 10.1001/archpsyc.58.9.810. [DOI] [PubMed] [Google Scholar]
- Carter BL, Tiffany ST. The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers. Experimental and Clinical Psychopharmacology. 2001;9:183–190. doi: 10.1037//1064-1297.9.2.183. [DOI] [PubMed] [Google Scholar]
- Coggins CR, Murrelle EL, Carchman RA, Heidbreder C. Light and intermittent cigarette smokers: A review (1989–2009) Psychopharmacology (Berl) 2009;207:343–363. doi: 10.1007/s00213-009-1675-4. [DOI] [PubMed] [Google Scholar]
- Dawkins L, Powell JH, Pickering A, Powell J, West R. Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction. 2009;104:850–858. doi: 10.1111/j.1360-0443.2009.02522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dierker L, Mermelstein R. Early emerging nicotine-dependence symptoms: A signal of propensity for chronic smoking behavior in adolescents. Journal of Pediatrics. 2010;156:818–822. doi: 10.1016/j.jpeds.2009.11.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donny EC, Griffin KM, Shiffman S, Sayette MA. The relationship between cigarette use, nicotine dependence, and craving in laboratory volunteers. Nicotine& Tobacco Research. 2008;10:447–455. doi: 10.1080/14622200801901906. [DOI] [PubMed] [Google Scholar]
- Dreiseitl S, Ohno-Machadob L. Logistic regression and artificial neural network classification models: A methodology review. Journal of Biomedical Informatics. 2002;35(2002):352–359. doi: 10.1016/s1532-0464(03)00034-0. [DOI] [PubMed] [Google Scholar]
- Edwards AC, Kendler KS. Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety. Nicotine & Tobacco Research. 2011;13:677–685. doi: 10.1093/ntr/ntr058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edwards G, Gross MM. Alcohol dependence: Provisional description of a clinical syndrome. BMJ. 1976;1:1058–1061. doi: 10.1136/bmj.1.6017.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nature Neuroscience. 2005;8:1481–1489. doi: 10.1038/nn1579. [DOI] [PubMed] [Google Scholar]
- Fiore MC, Bailey WC, Cohen SJ. Treating tobacco use and dependence: Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, U.S. Public Health Service; 2000. [Google Scholar]
- Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, Wewers ME. Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services, U.S. Public Health Service; 2008. [Google Scholar]
- Gloria R, Angelos L, Schaefer HS, Davis JM, Majeskie M, Richmond BS, Curtin JJ, Davidson RJ, Baker TB. An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation. Psychophysiology. 2009;46:681–693. doi: 10.1111/j.1469-8986.2009.00823.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harper PR. A review and comparison of classification algorithms for medical decision making. Health Policy. 2005;71:315–331. doi: 10.1016/j.healthpol.2004.05.002. [DOI] [PubMed] [Google Scholar]
- Harrell FE. Regression modeling strategies: With application to linear models, logistic regression, and survival analysis. Springer-Verlag; New York: 2001. [Google Scholar]
- Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
- Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction. 1989;84:791–799. doi: 10.1111/j.1360-0443.1989.tb03059.x. [DOI] [PubMed] [Google Scholar]
- Hendricks PS, Ditre JW, Drobes DJ, Brandon TH. The early time course of smoking withdrawal effects. Psychopharmacology (Berl) 2006;187:385–396. doi: 10.1007/s00213-006-0429-9. [DOI] [PubMed] [Google Scholar]
- Hiroi N, Scott D. Constitutional mechanisms of vulnerability and resilience to nicotine dependence. Molecular Psychiatry. 2009;14:653–667. doi: 10.1038/mp.2009.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holmes TH, Rahe RH. The Social Readjustment Rating Scale. Journal of Psychosomatic Research. 1967;11:213–218. doi: 10.1016/0022-3999(67)90010-4. [DOI] [PubMed] [Google Scholar]
- Hosmer DW, Lemeshow S. Applied Logistic Regression. 2. New York: John Wiley & Sons, Inc; 2000. [Google Scholar]
- Hughes JR. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine &Tobacco Research. 2007;9:315–327. doi: 10.1080/14622200701188919. [DOI] [PubMed] [Google Scholar]
- Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther. 2008;325(1):302–312. doi: 10.1124/jpet.107.132977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kawakami N, Takatsuka N, Inaba S, Shimizu H. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addictive Behaviors. 1999;24:155–166. doi: 10.1016/s0306-4603(98)00127-0. [DOI] [PubMed] [Google Scholar]
- Koob GF. The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction. 2006;101(Suppl 1):23–30. doi: 10.1111/j.1360-0443.2006.01586.x. [DOI] [PubMed] [Google Scholar]
- Kozlowski LT, Herman CP. The interaction of psychosocial and biological determinants of tobacco use: More on the boundary model. Journal of Applied Social Psychology. 1984;14:244–256. doi: 10.1111/j.1559-1816.1984.tb02234.x. [DOI] [Google Scholar]
- Loh WY. Regression trees with unbiased variable selection and interaction detection. Statistica Sinica. 2002;12:361–386. [Google Scholar]
- MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychological Methods. 2002;7:83–104. doi: 10.1037/1082-989X.7.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muthen LK, Muthen BO. Mplus User’s Guide. 6. Los Angeles, CA: Muthen & Muthen; 2010. [Google Scholar]
- Patrick CJ, Curtin JJ, Tellegen A. Development and validation of a brief form of the Multidimensional Personality Questionnaire. Psychological Assessment. 2002;14:150–163. doi: 10.1037//1040-3590.14.2.150. [DOI] [PubMed] [Google Scholar]
- Payne TJ, Smith PO, McCracken LM, McSherry WC, Antony MM. Assessing nicotine dependence: A comparison of the Fagerstrom Tolerance Questionnaire (FTQ) with the Fagerstrom Test for Nicotine Dependence (FTND) in a clinical sample. Addictive Behaviors. 1994;19:307–317. doi: 10.1016/0306-4603(94)90032-9. [DOI] [PubMed] [Google Scholar]
- Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. Journal of Abnormal Psychology. 2003;112:3–13. doi: 10.1037/0021-843X.112.1.3. [DOI] [PubMed] [Google Scholar]
- Piasecki TM, Niaura R, Shadel WG, Abrams D, Goldstein M, Fiore MC, Baker TB. Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology. 2000;109:74–86. doi: 10.1037/0021-843X.109.1.74. [DOI] [PubMed] [Google Scholar]
- Piasecki TM, Piper ME, Baker TB. Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives: II. Evidence from a laboratory self-administration assay. Journal of Abnormal Psychology. 2010a;119:513–523. doi: 10.1037/a0020235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piasecki TM, Piper ME, Baker TB. Tobacco dependence: Insights from investigations of self-reported smoking motives. Current Directions in Psycholical Science. 2010b;19:395–401. doi: 10.1177/0963721410389460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piasecki TM, Piper ME, Baker TB, Hunt-Carter EE. WISDM primary and secondary dependence motives: Associations with self-monitored motives for smoking in two college samples. Drug and Alcohol Dependence. 2011;114:207–216. doi: 10.1016/j.drugalcdep.2010.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piper ME, Bolt DM, Kim SY, Japuntich SJ, Smith SS, Niederdeppe J, Baker TB. Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. Journal of Abnormal Psychology. 2008;117:747–761. doi: 10.1037/a0013298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: Relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction. 2011;106:418–427. doi: 10.1111/j.1360-0443.2010.03173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piper ME, Loh WY, Smith SS, Japuntich SJ, Baker TB. Using decision tree analysis to identify risk factors for relapse to smoking. Substance Use & Misuse. 2011;46:492–510. doi: 10.3109/10826081003682222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piper ME, McCarthy DE, Baker TB. Assessing tobacco dependence: A guide to measure evaluation and selection. Nicotine & Tobacco Research. 2006;8:339–351. doi: 10.1080/14622200600672765. [DOI] [PubMed] [Google Scholar]
- Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Baker TB. Assessing dimensions of nicotine dependence: An evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM) Nicotine &Tobacco Research. 2008;10:1009–1020. doi: 10.1080/14622200802097563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piper ME, Piasecki TM, Federman EB, Bolt DM, Smith SS, Fiore MC, Baker TB. A multiple motives approach to tobacco dependence: The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Journal of Consulting and Clinical Psychology. 2004;72:139–154. doi: 10.1037/0022-006X.72.2.139. [DOI] [PubMed] [Google Scholar]
- Piper ME, Schlam TR, Cook JW, Sheffer MA, Smith SS, Loh WY, Baker TB. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology. 2011;216:569–578. doi: 10.1007/s00213-011-2250-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rios-Bedoya CF, Snedecor SM, Pomerleau CS, Pomerleau OF. Association of withdrawal features with nicotine dependence as measured by the Fagerstrom Test for Nicotine Dependence (FTND) Addictive Behaviors. 2008;33:1086–1089. doi: 10.1016/j.addbeh.2008.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson JD, Lam CY, Carter BL, Minnix JA, Cui Y, Versace F, Cinciripini PM. A multimodal approach to assessing the impact of nicotine dependence, nicotine abstinence, and craving on negative affect in smokers. Experimental and Clinical Psychopharmacology. 2011;19:40–52. doi: 10.1037/a0022114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews. 1993;18:247–291. doi: 10.1016/0165-0173(93)90013-p. [DOI] [PubMed] [Google Scholar]
- Sayette MA, Martin CS, Hull JG, Wertz JM, Perrott MA. Effects of nicotine deprivation on craving response covariation in smokers. Journal of Abnormal Psychology. 2003;112:110–118. [PMC free article] [PubMed] [Google Scholar]
- Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study. Pharmacology, Biochemistry, and Behavior. 2009;92:6–11. doi: 10.1016/j.pbb.2008.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shiffman S, Paty J. Smoking patterns and dependence: Contrasting chippers and heavy smokers. Journal of Abnormal Psychology. 2006;115:509–523. doi: 10.1037/0021-843X.115.3.509. [DOI] [PubMed] [Google Scholar]
- Shiffman S, Sayette MA. Validation of the nicotine dependence syndrome scale (NDSS): A criterion-group design contrasting chippers and regular smokers. Drug and Alcohol Dependence. 2005;79:45–52. doi: 10.1016/j.drugalcdep.2004.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shiffman S, Scharf DM, Shadel WG, Gwaltney CJ, Dang Q, Paton SM, Clark DB. Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. Journal of Consulting and Clinical Psychology. 2006;74:276–285. doi: 10.1037/0022-006X.74.2.276. [DOI] [PubMed] [Google Scholar]
- Shiffman S, Waters A, Hickcox M. The Nicotine Dependence Syndrome scale: A multidimensional measure of nicotine dependence. Nicotine &Tobacco Research. 2004;6:327–348. doi: 10.1080/1462220042000202481. [DOI] [PubMed] [Google Scholar]
- Siegel S. Classical conditioning, drug tolerance, and drug dependence. In: Smart RG, Glaser FB, Israel Y, Kalant R, Popham E, Schmidt W, editors. Research advances in alcohol and drug problems. 7. New York: Plenum; 1983. [Google Scholar]
- Smith AE, Cavallo DA, Dahl T, Wu R, George TP, Krishnan-Sarin S. Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers. Journal of Adolescent Health. 2008;43:46–54. doi: 10.1016/j.jadohealth.2007.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Solomon RL, Corbit JD. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev. 1974;81(2):119–145. doi: 10.1037/h0036128. [DOI] [PubMed] [Google Scholar]
- Stone AA, Schwartz JE, Neale JM, Shiffman S, Marco CA, Hickcox M, Cruise LJ. A comparison of coping assessed by ecological momentary assessment and retrospective recall. Journal of Personality and Social Psychology. 1998;74:1670–1680. doi: 10.1037/0022-3514.74.6.1670. [DOI] [PubMed] [Google Scholar]
- Takahashi Y, Roesch MR, Stalnaker TA, Schoenbaum G. Cocaine exposure shifts the balance of associative encoding from ventral to dorsolateral striatum. Frontiers in Integrative Neuroscience. 2007;1:1–10. doi: 10.3389/neuro.07/011.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tellegen A. Brief manual for the Multidimensional Personality Questionnaire. University of Minnesota; Minnesota, MN: 1982. [Google Scholar]
- Vanderschuren LJ, Di Ciano P, Everitt BJ. Involvement of the dorsal striatum in cue-controlled cocaine seeking. Journal of Neuroscience. 2005;25:8665–8670. doi: 10.1523/JNEUROSCI.0925-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Wong C. Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. Journal of Neuroscience. 2006;26:6583–6588. doi: 10.1523/JNEUROSCI.1544-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vollstadt-Klein S, Wichert S, Rabinstein J, Buhler M, Klein O, Ende G, Mann K. Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. Addiction. 2010;105:1741–1749. doi: 10.1111/j.1360-0443.2010.03022.x. [DOI] [PubMed] [Google Scholar]
- Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Socical Psychology. 1988;54:1063–1070. doi: 10.1037/0022-3514.54.6.1063. [DOI] [PubMed] [Google Scholar]
- Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Experimental and Clinical Psychopharmacology. 1999;7:354–361. doi: 10.1037/1064-1297.7.4.354. [DOI] [PubMed] [Google Scholar]
- Wikler A. Opioid dependence. New York: Plenum; 1980. [Google Scholar]




